U.P. Peter Eng

U.P. Peter Eng

Partner

Patents and Innovations

Experienced Patent Attorney

Peter specializes in strategic patent and innovation counseling for technology start-up companies.
Broad Range of Clients

His clients have included investors and companies in the clean technology, alternative energy, and life sciences sectors, as well as companies in the medical device, healthcare IT, and software industries.

Peter Eng is a partner at Wilson Sonsini Goodrich & Rosati, where he specializes in strategic patent and innovation counseling for technology start-up companies. Peter leads the renewable energy practice within his department and advises clients on patent and intellectual property matters.

His clients include investors and entrepreneurs who develop innovative technologies in the clean technology, alternative energy, and life sciences sectors. In addition, Peter has worked with medical device, healthcare IT, and software companies throughout his career at the firm. His litigation and corporate experience allows him to assist clients at all stages of growth in establishing and protecting intellectual property positions.

Peter joined Wilson Sonsini in 1997.

Experience

Peter joined Wilson Sonsini in 1997.

Education

J.D., Pepperdine University School of Law
B.S.E., Chemical Engineering, Tufts University

Associations and Memberships

Member, California State Bar Intellectual Property Section
Member, Santa Clara County Bar Association

Admissions

State Bar of California
State Bar of New Jersey
State Bar of New York
U.S. Patent and Trademark Office

Credentials

Education

J.D., Pepperdine University School of Law
B.S.E., Chemical Engineering, Tufts University

Associations and Memberships

Member, California State Bar Intellectual Property Section
Member, Santa Clara County Bar Association

Admissions

State Bar of California
State Bar of New Jersey
State Bar of New York
U.S. Patent and Trademark Office

Recent Insights

Client Highlights

On February 1, 2024, Fractyl Health, a metabolic therapeutics company focused on pioneering new approaches for the treatment of type 2 diabetes (T2D) and obesity, announced the pricing of its initial public offering of 7,333,333 shares of common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $110.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Fractyl Health. Wilson Sonsini Goodrich & Rosati advised Fractyl Health on patent matters related to the transaction.

Learn More

Client Highlights

On January 26, 2023, Spatial Labs, a web3 infrastructure and hardware company founded by Iddris Sandu, announced $10 million in seed funding led by Blockchain Capital with participation from Marcy Venture Partners, the firm co-founded by Jay-Z. Wilson Sonsini Goodrich & Rosati advised Spatial Labs on the transaction.

Learn More